$AVY

Insider moves at Avery Dennison (NYSE: AVY) detailed

Avery Dennison (AVY) director William R. Wagner disposed of 3,412 shares of common stock and acquired 344 restricted stock units (RSUs) on September 1, 2026, according to an SEC Form 4 filing.

Original reporting
Published Sep 1, 2026, 10:33 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 2, 2026, 1:24 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$AVY
Bearish
medium confidence
Mentioned
$AVY
Relevance
4/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

$AVYBearishLow
01

Why it matters

Director's sale may cause modest price movement; investors may watch for further insider activity.

02

Market read

Insider sale may lead to slight downward pressure on AVY, but overall market impact is limited.

03

What to watch

No disclosed reason; could be tax planning.

Relevance 4/10Novelty 5/10Timing: filed today

Background

SEC Form 4 filing discloses insider transactions for Avery Dennison.

Company-level read

Ticker impact

$AVYBearishMedium confidence
Context

Director William R. Wagner sold 3,412 shares of AVY on 09/01/2026, a disclosed insider sale.

Expected impact

Potential modest downward pressure on AVY stock.

Evidence & confidence

Sale size is modest relative to market cap, but director involvement could influence perception.

Market effects

Minimal impact on materials sector.

US market only.

Limited global relevance.

Counterpoint

Sale could be routine portfolio rebalancing, no bearish implication.

Key entities

  • William R. Wagner

    Director of Avery Dennison who sold 3,412 shares.

  • Avery Dennison Corp

    Materials company (ticker AVY) subject of the insider sale.

Related articles

$AVYHighAI 8/10

Avery Dennison (AVY) Earnings Beat Keeps Fair Value In Focus

Avery Dennison (AVY) reported Q2 revenue of $2.46B, up 10.9% YoY, with organic revenue and EBITDA exceeding estimates. Despite the beat, the share price remained unchanged. The company's fair value is estimated at $200.30, suggesting undervaluation. Growth drivers include smart labels, RFID, and sustainable packaging solutions. However, risks include tariff pressures and slower adoption of intelligent labels in apparel.

$AVYMed

Q2 Earnings Review: Industrial Packaging Stocks Led by Avery Dennison (NYSE:AVY)

Packaging Corporation of America (PCA) reported Q2 revenue of $2.49B, up 14.7% YoY, but missed EPS estimates. International Paper (IP) reported $6.00B revenue, down 11.3% YoY, missing expectations. Silgan Holdings (SLGN) reported $1.64B revenue, up 6.8% YoY, beating estimates. PCA and SLGN stocks are up 1.9% and down 19.7% since reporting, respectively. IP stock is down 18.1% since reporting.

$AVYMed

Avery Dennison Stock Outlook: Is Wall Street Bullish or Bearish?

Avery Dennison (AVY) reported Q2 2026 revenue of $2.5B, beating estimates. Adjusted EPS was $2.89, also topping forecasts. Analysts expect full-year EPS of $10.15, up 6.5%. AVY stock has underperformed the S&P 500 but outperformed its industry ETF. Analysts rate it 'Moderate Buy' with a mean price target of $199.

$AVYMed

Will Stronger 2026 Guidance and Buybacks Reshape Avery Dennison’s (AVY) Earnings and Capital Return Narrative?

Avery Dennison reported Q2 2026 results with sales of $2,462.9 million and net income of $204.1 million. Diluted EPS from continuing operations rose to $2.67 from $2.41 a year earlier. The company raised full-year 2026 guidance to reported EPS of $9.40–$9.70 and sales growth of 5%–6%, and completed a $482.6 million buyback of 2,865,010 shares.

$AVYMedAI 8/10

Avery Dennison Q2 Earnings Call Highlights

Avery Dennison (NYSE:AVY) reported Q2 segment updates on an earnings call. Materials Group organic sales rose 10% and adjusted EBITDA increased 17% with margin up 20 bps. Solutions Group organic sales rose 3% and adjusted EBITDA margin reached 18.6%. The company reinstated 2026 guidance: adjusted EPS $10 to $10.30 and organic sales growth 3% to 4%.